NFA
ASMB icon

Nationwide Fund Advisors’s Assembly Biosciences ASMB Stock Holding History

Nationwide Fund Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-650
Closed -$272K – 161
2017
Q3 		$272K Hold
650
– – ﹤0.01% 2485
2017
Q2 		$161K Buy
+650
New +$183K ﹤0.01% 2720
2016
Q2 		– Sell
-759
Closed -$46K – 3265
2016
Q1 		$46K Hold
759
– – ﹤0.01% 2998
2015
Q4 		$68K Hold
759
– – ﹤0.01% 2937
2015
Q3 		$87K Hold
759
– – ﹤0.01% 2935
2015
Q2 		$175K Buy
+759
New +$146K ﹤0.01% 2774
2013
Q3 		– Sell
-136
Closed -$20K – 3261
2013
Q2 		$20K Buy
+136
New +$21.3K ﹤0.01% 3084

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Nationwide Fund Advisors's ASMB Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Assembly Biosciences (ASMB) in Q4 2017, closing a stake of 650 shares — an estimated $272K sold.

Nationwide Fund Advisors first reported a position in ASMB in Q2 2013 and held it in 7 quarters. The position peaked at $272K in Q3 2017. 98 funds tracked by Wall St. Rank hold ASMB as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Assembly Biosciences position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 650 Assembly Biosciences shares in Q4 2017, an estimated $272K.
  • Nationwide Fund Advisors first reported a position in Assembly Biosciences in Q2 2013 and held it in 7 quarters.
  • Nationwide Fund Advisors's Assembly Biosciences position peaked at $272K in Q3 2017.
  • 98 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.